Home
>
National Drug Code (NDC)
>
LEUKERAN
LEUKERAN - 0173-0635-35 - (chlorambucil)
Drug Information of LEUKERAN
| Product NDC: | 0173-0635 |
| Proprietary Name: | LEUKERAN |
| Non Proprietary Name: | chlorambucil |
| Active Ingredient(s): | 2 mg/1 & nbsp; chlorambucil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LEUKERAN
| Product NDC: | 0173-0635 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA010669 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19850213 |
Package Information of LEUKERAN
| Package NDC: | 0173-0635-35 |
| Package Description: | 50 TABLET, FILM COATED in 1 BOTTLE (0173-0635-35) |
NDC Information of LEUKERAN
| NDC Code | 0173-0635-35 |
| Proprietary Name | LEUKERAN |
| Package Description | 50 TABLET, FILM COATED in 1 BOTTLE (0173-0635-35) |
| Product NDC | 0173-0635 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | chlorambucil |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19850213 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | CHLORAMBUCIL |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
